60.77
Atricure Inc stock is traded at $60.77, with a volume of 1.30M.
It is up +1.36% in the last 24 hours and up +23.32% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$59.95
Open:
$59.63
24h Volume:
1.30M
Relative Volume:
1.19
Market Cap:
$3.09B
Revenue:
$534.53M
Net Income/Loss:
$-11.45M
P/E Ratio:
-252.05
EPS:
-0.2411
Net Cash Flow:
$48.28M
1W Performance:
+2.79%
1M Performance:
+23.32%
6M Performance:
+105.23%
1Y Performance:
+68.38%
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ATRC
Atricure Inc
|
60.77 | 3.09B | 534.53M | -11.45M | 48.28M | -0.2411 |
|
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
|
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-11-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
AtriCure CTO Salvatore Privitera sells $271,140 in stock By Investing.com - Investing.com Australia
Form 4 AtriCure Inc For: 24 September By Investing.com - Investing.com UK
Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) officer sells shares at $60 each under a trading plan. - Stock Titan
Biotech Stocks At 52-Week HighsTKNO, MRNA, ATRC, ILMN - RTTNews
AtriCure, Inc. (ATRC) Stock forecasts - Yahoo Finance Singapore
AtriCure, Inc. (ATRC) Stock Forecasts - ca.finance.yahoo.com
Form 144 ATRICURE For: 23 September - Investing.com India
Form 144 ATRICURE For: 23 September By Investing.com - Investing.com Canada
After two September sales, AtriCure (ATRC) officer Salvatore Privitera proposes another worth $271,140. - Stock Titan
AtriCure stock hits 52-week high at $59.91 - Investing.com
AtriCure stock hits 52-week high at $59.91 By Investing.com - Investing.com Canada
AtriCure, Inc. (ATRC) Stock Price, News, Quote & History - Yahoo! Finance Canada
AtriCure stock falls 1.45 percent as earnings approach - AD HOC NEWS
AtriCure, Inc.(NasdaqGM: ATRC) added to S&P 1000 - marketscreener.com
AtriCure, Inc.(NasdaqGM: ATRC) added to S&P 600 Health Care - marketscreener.com
AtriCure, Inc.(NasdaqGM: ATRC) added to S&P Composite 1500 - marketscreener.com
AtriCure stock holds firm as recent insider buying follows solid 2026 results - AD HOC NEWS
Atricure Stock Price Forecast. Should You Buy ATRC? - StockInvest.us
AtriCure stock gains as analysts highlight upside and valuation risks - AD HOC NEWS
AtriCure Inc (ATRC) Shares Surge 3.4% -- What GF Score of 75 Tel - GuruFocus
Stifel reiterates Buy rating on AtriCure stock, $65 target By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on AtriCure stock, $65 target - Investing.com
Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $65 - Moomoo
AtriCure Director Regina E. Groves Sells 5,313 Shares at $54.22 Each (NASDAQ: ATRC) - Kalkine Media
Insider Selling: Regina E Groves Unloads $288K Of AtriCure Stock - Benzinga
Director Regina Groves Sells 5,313 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure director Regina Groves sells $288,070 of stock By Investing.com - Investing.com South Africa
AtriCure director Regina Groves sells $288,070 of stock - Investing.com
AtriCure (NASDAQ: ATRC) director sells shares with no 10b5-1 plan filed - Stock Titan
AtriCure stock hits 52-week high at 55.83 USD By Investing.com - Investing.com Nigeria
AtriCure stock hits 52-week high at 55.83 USD - Investing.com
AtriCure Executive Stock Sale Analysis - Intellectia AI
AtriCure CTO Sells 3,657 Shares - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Nigeria
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares - investing.com
AtriCure (ATRC) CTO discloses pre-set stock sale - Stock Titan
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing - Stock Traders Daily
AtriCure (ATRC) Momentum Meets A Pricey Narrative On $47 Fair Value - simplywall.st
AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC) - Kalkine Media
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com India
AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan - Kalkine Media
Atricure CTO Salvatore Privitera sells $407,557 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Chief Technical Officer Salvatore Privitera Sells 7,763 Shares - GuruFocus
Atricure CTO Salvatore Privitera sells $407,557 in stock - Investing.com
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):